Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Chronic-Phase trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Phase: Phase 2 Country / region: Italy Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20052
20061
20071
20091
20121
20131
20141
20151
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Fred Hutchinson Cancer Center3
Gruppo Italiano Malattie EMatologiche dell'Adulto2
European Organisation for Research and Treatment of Cancer - EORTC1
Niguarda Hospital1
Novartis Pharmaceuticals1
Takeda1
University of Bologna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive5
Burkitt Lymphoma4
Hodgkin Disease4
Immunoblastic Lymphadenopathy4
Leukemia, Hairy Cell4
Leukemia, Lymphocytic, Chronic, B-Cell4
Leukemia, Myeloid, Acute4
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Follicular4

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.